Key result
Tailored therapy targeting underlying causes remains the primary approach to minimize future events in MINOCA.
Why the study?
MINOCA presents significant diagnostic and therapeutic challenges due to its multifactorial etiology despite insignificant coronary artery disease on angiography.
This review highlights that MINOCA management requires a tailored approach based on the specific underlying etiology to effectively reduce future cardiac risk.
Answers are grounded in this paper and cite their sources.
Tailored etiology-driven therapy may lower risk in MINOCA; leaves open optimal strategies pending randomized trials.
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a clinical entity characterized by the presence of symptoms of myocardial infarction (MI) and evidence of myocardial ischemia, despite coronary angiography revealing insignificant coronary artery disease. Therefore, this condition presents significant diagnostic and therapeutic challenge. This paper provides a concise overview of therapeutic strategies for MINOCA patients, highlighting the complexities and approaches to managing this unique patient population. The multifactorial etiology of MINOCA requires an adapted approach, so the therapeutic approach to patients with MINOCA is primarily focused on addressing the underlying causes and minimizing the risk of future cardiac events.
No takes yet. Share an insight, caveat, or question.
Bešenji et al. (2023) studied this question. The therapeutic approach for patients with MINOCA focuses on addressing underlying causes to minimize future cardiac events.
Synapse has enriched 10 related papers. Consider them for comparative context: